Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.

Article Details

Citation

Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, Lee H, Park JH, Kim HC, Kim JS, Kang YK

Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.

Dig Dis Sci. 2006 Jun;51(6):1043-6.

PubMed ID
16865565 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
ImatinibMast/stem cell growth factor receptor KitProteinHumans
Yes
Antagonist
Details